Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
Jacob Christian Lindegaard, Primož Petrič, Maximilian Schmid, N. Nesvacil, Christine Haie-Méder, Lars Fokdal, Alina Sturdza, Peter Hoskin, Umesh Mahantshetty, Barbara Šegedin, Kjersti Bruheim, Fleur Huang, Bhavana Rai, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik Van Limbergen, Bradley R. Pieters, Li Tee Tan, Remi A. Nout, Astrid A.C. de Leeuw, Kathrin Kirchheiner, Sofia Spampinato, Ina M. Jürgenliemk‐Schulz, Kari Tanderup, Christian Kirisits, Richard Pötter
Topics & Concepts
Cervical cancerMedicineMulticenter studyUterine cancerOncologyRegressionCancerInternal medicineGynecologyStatisticsRandomized controlled trialMathematicsEndometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentGynecological conditions and treatments